These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 16627933

  • 1. The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
    Chuu JY, Taylor JL, Tinklenberg J, Noda A, Yesavage J, Murphy GM.
    J Alzheimers Dis; 2006 Mar; 9(1):43-9. PubMed ID: 16627933
    [Abstract] [Full Text] [Related]

  • 2. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N, Nikolac M, Nedic G, Mustapic M, Borovecki F, Hajnsek S, Presecki P, Pavlovic M, Mimica N, Muck Seler D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):356-62. PubMed ID: 21044653
    [Abstract] [Full Text] [Related]

  • 3. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, Nathan PJ, Maruff P, Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.
    Neurobiol Aging; 2013 Nov 30; 34(11):2457-64. PubMed ID: 23769397
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    Stonnington CM, Velgos SN, Chen Y, Syed S, Huentelman M, Thiyyagura P, Lee W, Richholt R, Caselli RJ, Locke DEC, Lu B, Reiman EM, Su Y, Chen K.
    J Alzheimers Dis; 2020 Nov 30; 78(2):721-734. PubMed ID: 33044176
    [Abstract] [Full Text] [Related]

  • 6. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
    Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH.
    Neuropsychobiology; 2004 Nov 30; 49(1):10-2. PubMed ID: 14730194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB, Hong Z.
    Neuropsychobiology; 2007 Nov 30; 55(3-4):151-5. PubMed ID: 17657167
    [Abstract] [Full Text] [Related]

  • 9. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, Maruff P.
    Int Psychogeriatr; 2017 Nov 30; 29(11):1825-1834. PubMed ID: 28720165
    [Abstract] [Full Text] [Related]

  • 10. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH.
    Arch Gen Psychiatry; 2006 Jul 30; 63(7):731-40. PubMed ID: 16818862
    [Abstract] [Full Text] [Related]

  • 11. BDNF val66met polymorphism affects aging of multiple types of memory.
    Kennedy KM, Reese ED, Horn MM, Sizemore AN, Unni AK, Meerbrey ME, Kalich AG, Rodrigue KM.
    Brain Res; 2015 Jul 01; 1612():104-17. PubMed ID: 25264352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R, Gürvit H, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Baran B, Kalem SA, Büyükgök D, Direskeneli GS.
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct 01; 159B(7):850-8. PubMed ID: 22911909
    [Abstract] [Full Text] [Related]

  • 14. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
    Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM.
    Neurobiol Aging; 2006 Dec 01; 27(12):1834-7. PubMed ID: 16343697
    [Abstract] [Full Text] [Related]

  • 15. The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced hippocampus perfusion in frontotemporal lobar degeneration.
    Borroni B, Bianchi M, Premi E, Alberici A, Archetti S, Paghera B, Cerini C, Papetti A, Padovani A.
    J Alzheimers Dis; 2012 Dec 01; 31(2):243-51. PubMed ID: 22596272
    [Abstract] [Full Text] [Related]

  • 16. BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease.
    Lim YY, Laws SM, Perin S, Pietrzak RH, Fowler C, Masters CL, Maruff P, AIBL Research Group.
    Genes Brain Behav; 2021 Jun 01; 20(5):e12724. PubMed ID: 33369083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.
    Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T, Alzheimer's Disease Neuroimaging Initiative.
    Neuroreport; 2010 Aug 23; 21(12):802-7. PubMed ID: 20613678
    [Abstract] [Full Text] [Related]

  • 20. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.
    Neuropsychobiology; 2010 Aug 23; 61(2):71-8. PubMed ID: 20016225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.